Home › Compare › SCPS vs DIVO

SCPS vs DIVO: Dividend Comparison 2026

SCPS yields 500000.00% · DIVO yields 6.62%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SCPS wins by $4.663521010693878e+33M in total portfolio value
10 years
SCPS
SCPS
● Live price
500000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.663521010693878e+33M
Annual income
$4,661,686,961,926,996,000,000,000,000,000,000,000,000.00
Full SCPS calculator →
DIVO
DIVO
● Live price
6.62%
Share price
$44.00
Annual div
$2.91
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$31.0K
Annual income
$1,008.47
Full DIVO calculator →

Portfolio growth — SCPS vs DIVO

📍 SCPS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSCPSDIVO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SCPS + DIVO cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
SCPS pays
DIVO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SCPS
Annual income on $10K today (after 15% tax)
$42,500,000.00/yr
After 10yr DRIP, annual income (after tax)
$3,962,433,917,637,946,000,000,000,000,000,000,000,000.00/yr
DIVO
Annual income on $10K today (after 15% tax)
$562.67/yr
After 10yr DRIP, annual income (after tax)
$857.20/yr
At 15% tax rate, SCPS beats the other by $3,962,433,917,637,946,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SCPS + DIVO for your $10,000?

SCPS: 50%DIVO: 50%
100% DIVO50/50100% SCPS
Portfolio after 10yr
$2.331760505346939e+33M
Annual income
$2,330,843,480,963,498,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.96%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SCPS buys
0
DIVO buys
0
No recent congressional trades found for SCPS or DIVO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSCPSDIVO
Forward yield500000.00% ✓6.62%
Annual dividend / share$2.00$2.91 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$4.663521010693878e+33M$31.0K ✓
Annual income after 10y$4,661,686,961,926,996,000,000,000,000,000,000,000,000.00 ✓$1,008.47
Total dividends collected$4.6634009849658873e+33M$8.4K ✓
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: SCPS vs DIVO ($10,000, DRIP)

YearSCPS PortfolioSCPS Income/yrDIVO PortfolioDIVO Income/yrGap
1← crossover$50,010,700$50,000,000.00$11,362$661.96+$50.00M → SCPS
2$233,748,371,262$233,694,859,813.08$12,860$702.91+$233748.36M → SCPS
3$1,021,074,511,412,696$1,020,824,400,655,446.10$14,504$743.56+$1021074511.40M → SCPS
4$4,168,597,328,794,951,700$4,167,504,779,067,739,000.00$16,303$783.73+$4168597328794.94M → SCPS
5$15,905,475,114,600,665,000,000$15,901,014,715,458,854,000,000.00$18,268$823.31+$15905475114600664.00M → SCPS
6$56,718,938,532,531,060,000,000,000$56,701,919,674,158,435,000,000,000.00$20,408$862.17+$56718938532531060736.00M → SCPS
7$189,031,807,435,623,860,000,000,000,000$188,971,118,171,394,040,000,000,000,000.00$22,737$900.20+$1.8903180743562385e+23M → SCPS
8$588,799,810,476,518,260,000,000,000,000,000$588,597,546,442,562,100,000,000,000,000,000.00$25,266$937.31+$5.8879981047651824e+26M → SCPS
9$1,714,064,268,114,722,600,000,000,000,000,000,000$1,713,434,252,317,512,700,000,000,000,000,000,000.00$28,008$973.42+$1.7140642681147225e+30M → SCPS
10$4,663,521,010,693,878,300,000,000,000,000,000,000,000$4,661,686,961,926,996,000,000,000,000,000,000,000,000.00$30,977$1,008.47+$4.663521010693878e+33M → SCPS

SCPS vs DIVO: Complete Analysis 2026

SCPS — Stock

Scopus BioPharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases. The company lead development programs are immuno-oncology gene therapy for the treatment of various cancers. It offers Duet Platform, a CpG signal transducer and activator of transcription 3 (STAT3) inhibitors; and MRI-1867, rationally designed, orally available, dual-action, hybrid, and small molecule that is an inverse agonist of the endocannabinoid system/cannabinoid receptor 1, as well as an inhibitor of inducible nitric oxide synthase. Scopus BioPharma Inc. has strategic partnerships with the City of Hope, National Institutes of Health Program, and The Hebrew University of Jerusalem for its lead development and other programs. The company was formerly known as Project18 Inc. and changed its name to Scopus BioPharma Inc. in December 2017. Scopus BioPharma Inc. was incorporated in 2017 and is headquartered in New York, New York.

Full SCPS Calculator →

DIVO — ETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →
📬

Get this SCPS vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SCPS vs SCHDSCPS vs JEPISCPS vs OSCPS vs KOSCPS vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.